A systematic review of hydromorphone in acute and chronic pain

Journal of Pain and Symptom Management

Volumn 25, Issue 2, 2003, Pages 169-178

  Quigley, Columba ^a   Wiffen, Phil ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Cancer; Fentanyl; Hydromorphone; Morphine; Opioids; Oxycodone; Pain; Placebo; Randomized controlled trials; Systematic review

Indexed keywords

HYDROMORPHONE; OPIATE;

ACUTE DISEASE; ADOLESCENT; ANALGESIA; CANCER PAIN; CHILD; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG POTENCY; HUMAN; PAIN ASSESSMENT; PATIENT; REVIEW; SCORING SYSTEM; SIDE EFFECT;

EID: 0037315594     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(02)00643-7     Document Type: Review

References (51)

1. World Health Organization Cancer pain relief. 2nd Ed:1996;World Health Organization, Geneva, Switzerland.
2. Cherny N.J., Chang F., Frager G.et al. Opioid pharmacotherapy in the management of cancer pain. a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration Cancer. 76:1995;1283-1293.
3. Chaplan S.R., Duncan S.R., Brodsky J.B.et al. Morphine and hydromorphone epidural analgesia. Anesthesiology. 77:1992;1090-1094.
4. Goodarzi M. Comparison of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopedic surgery. Pediatr Anesth. 9:1999;419-422.
5. Jacox A., Carr D., Payne R. New clinical practice guidelines for the management of pain in patients with cancer. N Engl J Med. 330:1993;651-655.
6. Pereira J., Lawlor P., Vigano A.et al. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing J Pain Symptom Manage. 22:2001;672-687.
7. Jadad A.R., Moore R.A., Carroll D.et al. Assessing the quality of reports of randomized clinical trials. is blinding necessary? Control Clin Trials. 17:1996;1-12.
8. Napp Laboratories. A comparative efficacy and tolerability study of Palladone capsules and MST Continus tables in patients with cancer pain. Data on file.
9. Goldberg R.I., Shuman F.I. Oral hydromorphone in trauma. Curr Ther Res. 7:1965;284-288.
10. Jain A.K., McMahon F.G., Reder R.et al. A placebo-controlled study of an oral solution of 5 and 10mg of hydromorphone hydrochloride in postoperative pain. Clin Pharmacol Ther. 45:1989;175.
11. Parker E.O., Brookshire G.L., Bartel S.J.et al. Effects of epinephrine on epidural fentanyl, sufentanil and hydromorphone for postoperative pain. Anesthesiology. 63:1985;A235.
12. Miller M.G., McCarthy N., O'Boyle C.A., Kearney M. Continuous subcutaneous infusion of morphine vs. hydromorphone in patients with cancer pain. a retrospective study Pain. 72:1997;79-85.
13. Moriarty M., McDonald C.J., Miller A.J. A randomised crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain. J Clin Res. 2:1999;1-8.
14. Houde R.W. Clinical analgesic studies of hydromorphone. Foley K.M., Inturrisi C.E. Advances in Pain Research and Therapy, Vol 8. 1986;129-135 Raven Press, New York.
15. Hagen N.A., Babul N. Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer. 79:1997;1428-1437.
16. Bruera E., Sloan P., Mount B.et al. A randomized, double-blind, double-dummy, cross-over trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. J Clin Oncol. 14:1996;1713-1717.
17. Hays H., Hagen N., Thirlwell M.et al. Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. Cancer. 74:1994;1808-1816.
18. Bruera E., Brenneis C., Michaud M.et al. Patient-controlled subcutaneous infusion for the treatment of cancer pain. J Natl Cancer Inst. 80:1988;1152-1154.
19. Vanier M.C., Labrecque G., Lepage-Savary D.et al. Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain. a pilot study Pain. 53:1993;27-32.
20. Moulin D.E., Kreeft J.H., Murray-Parsons N.et al. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet. 337:1991;465-468.
21. Collins J.J., Geake J., Grier H.E.et al. Patient-controlled analgesia for mucositis pain in children. a three-period crossover study comparing morphine and hydromorphone J Pediatr. 129:1996;722-728.
22. Lavoie J, Vischoff D, Villeneuve E. Comparison of caudally administered morphine vs. hydromorphone in paediatric cardiac surgical patients. Br J Anaesth 1996:76(S1):35.
23. Sharar S.R., Bratton S.L., Carrougher G.J.et al. A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia. J Burn Care Rehabil. 19:1998;516-521.
24. Hanna C., Mazuzan J.E., Abajian J. An evaluation of dihydromorphinone in treating postoperative pain. Anesth Analg. 41:1962;755-761.
25. Rapp S.E., Egan K.J., Ross B.K.et al. A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia. Anesth Analg. 82:1996;1043-1048.
26. Coda B.A., O'Sullivan B., Donaldson G.et al. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain. 72:1997;333-346. -.
27. Wallenstein S.L., Houde R.W., Portenoy R.et al. Clinical analgesic assay of repeated and single doses of heroin and hydromorphone. Pain. 41:1990;5-13.
28. Deutsch E.V. Postoperative analgesia with hydromorphone and meperidine. a double-blind comparison Anesth Analg. 47:1968;669-671.
29. Jasani N.B., O'Connor R.E., Bouzoukis J.K. Comparison of hydromorphone and meperidine for ureteral colic. Acad Emerg Med. 1:1994;539-543.
30. Nasits B.J. Dental evaluation of Hydromorphone (Dilaudid) for oral and maxillo-facial surgery. Tex Dent J. 87:1969;4-6.
31. Chestnut D.H., Choi W.W., Isbell T.J. Epidural hydromorphone for postcesarean analgesia. Obstet Gynecol. 68:1986;65-69.
32. Gaeta R.R., Macario A., Brodsky J.B.et al. Pain outcomes after thoracotomy. lumbar epidural hydromorphone versus intrapleural bupivacaine J Cardiothor Vasc Anesth. 9:1995;534-537.
33. Uden P., Starck C.J., Berger T. Comparison of indomethacin and dihydromorphinone in acute, biliary stone pain. Current Ther Res. 36:1984;1228-1234.
34. Liu S., Carpenter R.L., Mulroy M.F.et al. Intravenous versus epidural administration of hydromorphone. Anesthesiology. 82:1995;682-688.
35. Parker R.K., White P.F. Epidural patient-controlled analgesia. an alternative to intravenous patient-controlled analgesia for pain relief after cesarean delivery Anesth Analg. 75:1992;245-251.
36. Henderson S.K., Matthew E.B., Cohen H.et al. Epidural hydromorphone. a double-blind comparison with intramuscular hydromorphone for postcesarean section analgesia Anesthesiology. 66:1987;825-830.
37. Schultz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias. J Am Med Assoc. 273:1995;408-412.
38. Moore A., Moore O., McQuay H., Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomized controlled trials of analgesics. use of pain intensity and visual analogue scales Pain. 69:1997;311-315.
39. Babul N., Darke A.C. Hydromorphone and metabolite pharmacokinetics in children. J Pain Symptom Manage. 10:1995;335-337.
40. Moore R.A., Gavaghan D., Tramer M.R.et al. Size is everything-large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain. 78:1998;209-216.
41. Quigley C. Hydromorphone for acute and chronic pain (Cochrane Review). In: The Cochrane Library 2002 (in press).
42. Dougherty T.B., Baysinger C.L., Henenberger J.C., Gooding D.J. Epidural hydromorphone with and without epinephrine for post operative analgesia. Anesth Analg. 68:1989;318-322.
43. Drakeford M.K., Pettine K.A., Brookshire L., Ebert F. Spinal narcotics for postoperative analgesia in total joint arthroplasty. J Bone Joint Surg. 73:1991;424-428.
44. Flaherty S.A., Faut-Callahan M., Paice J.A.et al. A comparison of analgesic efficacy, patient satisfaction and cost of three spinal-epidural analgesic regimens in the labouring parturient. J Am Assoc Nurse Anesth. 65:1997;384.
45. Halpern S.H., Arellano R., Preston R.et al. Epidural morphine vs. hydromorphone in post-caesarean section patients. Can J Anaesth. 6:1996;595-598.
46. Mahler D.L., Forrest W.H. Relative analgesic potencies of morphine and hydromorphone in postoperative pain. Anesthesiology. 42:1975;602-607.
47. Parker R.K., Sawaki Y., White P.F. Epidural patient-controlled analgesia. influence of bupivacaine and hydromorphone basal infusion on pain control after cesarean delivery Anesth Analg. 75:1992;740.
48. Parker R.K., Holtman B., White P.F. Patient-controlled epidural analgesia. interactions between nalbuphine and hydromorphone Anesth Analg. 84:1997;747-763.
49. Searle N.R., Roy M., Bergeron G.et al. Hydromorphone patient-controlled analgesia (PCA) after coronary artery bypass surgery. Can J Anaesth. 41:1994;198-205.
50. Swica L., Midgley J., Nunn R.et al. Patient controlled epidural analgesia with hydromorphone versus single dose epidural morphine for post-cesarean analgesia. Can J Anesth. 45:1998;A63.
51. Urquhart M.L., Klapp K., White P.F. Patient-controlled analgesia. a comparison of intravenous versus subcutaneous hydromorphone Anesthesiology. 69:1988;428-432.